EUVIMEDEUVIMED entdecken
MetaanalyseSystematische ÜbersichtOpen Access · CC BY-NC-ND 4.0

GnRH agonist pretreatment for frozen embryo transfer among women with polycystic ovary syndrome: a narrow systematic review and meta-analysis of randomized controlled trials

Yiqing Wu, Mixue Tu, Yifeng Liu, Dan Zhang

Reproductive Biology and Endocrinology · 2024

DOI: 10.1186/s12958-024-01293-9 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift Reproductive Biology and Endocrinology, 2024. Verfasst von Yiqing Wu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Women's Reproductive Health Research Key Laboratory of Zhejiang Province and Department of Reproductive Endocrinology, Women's Hospital, Zhejiang Uni…. Hauptthemen laut MEDLINE: Embryo Transfer, Gonadotropin-Releasing Hormone, Infertility, Female, Polycystic Ovary Syndrome. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Natural Science Foundation of Zhejiang Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Frozen embryo transfer (FET) is usually recommended for women with polycystic ovary syndrome (PCOS) undergoing In vitro fertilization (IVF). While there is no consensus as to the optimal protocol of endometrial preparation for FET. The effect of gonadotropin-releasing hormone agonist (GnRH-a) pretreatment for FET among women with PCOS remains controversial. PURPOSE: We intend to explore whether GnRH-a pretreatment could improve clinical outcomes for women with PCOS undergoing FET. METHODS: PubMed, Embase, ClinicalTrials.gov, Cochrane Library, and Web of Science were searched up to May 16, 2024. Eligible studies involved patients with PCOS undergoing FET and receiving GnRH-a pretreatment for endometrial preparation, with artificial cycle (AC) as the control therapy. Only randomized controlled trials (RCTs) published in Chinese and English were included. Data extraction was performed independently by two authors. Effect was quantified using odd ratios (ORs) with 95% confidence intervals (CIs) using random-effect models with the Mantel-Hansel (M-H) method in Revman software. Quality of outcomes was evaluated using the GRADEpro system. Primary outcomes contained the clinical pregnancy rate, miscarriage rate, and live birth rate. Secondary outcomes included the incidence of preterm labor and gestational diabetes mellitus (GDM). RESULTS: Ninety-seven records were initially retrieved, with 21 duplicates and 65 articles excluded after title and abstract screening. Seven studies were excluded due to retrospective design, leaving three RCTs with 709 participants. Among them, 353 received GnRH-a pretreatment as the intervention group and 356 received AC as the control group. No significant differences were observed in the clinical pregnancy rate (OR 1.09, 95% CI 0.75 to 1.56, P = 0.66), miscarriage rate (OR 0.73, 95% CI 0.28 to 1.90, P = 0.52), live birth rate (OR 0.87, 95% CI 0.61 to 1.25, P = 0.46), and the risk of preterm labor (OR 1.45, 95% CI 0.79 to 2.65, P = 0.23) and GDM (OR 0.73, 95% CI 0.37 to 1.48, P = 0.39) between the two groups. CONCLUSIONS: In this meta-analysis, GnRH-a pretreatment does not confer any advantages and appears unnecessary for women with PCOS undergoing FET. Additional RCTs should focus on maternal complications and the health of offspring.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Embryo TransferGonadotropin-Releasing HormoneInfertility, FemalePolycystic Ovary SyndromePregnancy RateFemaleHumansPregnancyCryopreservationFertility Agents, FemaleFertilization in VitroRandomized Controlled Trials as Topic

Stichwörter der Autor:innen

Artificial cycleEndometrial preparationFrozen embryo transferGnRH agonistMaternal and neonatal outcomesPolycystic ovary syndromePregnancy outcomes

Substanzen

Fertility Agents, FemaleGonadotropin-Releasing Hormone

Autor:innen und Institutionen

  • Women's Reproductive Health Research Key Laboratory of Zhejiang Province and Department of Reproductive Endocrinology, Women's Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, 310006, People's Repub…
  • Key Laboratory of Reproductive Genetics (Zhejiang University), Ministry of Education, Hangzhou, Zhejiang, 310006, People's Republic of China. zhangdan@zju.edu.cn.

Förderung

  • Natural Science Foundation of Zhejiang Province

Zitieren

APA

Wu, Y., Tu, M., Liu, Y., & Zhang, D. (2024). GnRH agonist pretreatment for frozen embryo transfer among women with polycystic ovary syndrome: a narrow systematic review and meta-analysis of randomized controlled trials. Reproductive Biology and Endocrinology. https://doi.org/10.1186/s12958-024-01293-9

Vancouver

Wu Y, Tu M, Liu Y, Zhang D. GnRH agonist pretreatment for frozen embryo transfer among women with polycystic ovary syndrome: a narrow systematic review and meta-analysis of randomized controlled trials. Reproductive Biology and Endocrinology. 2024. doi:10.1186/s12958-024-01293-9

BibTeX
@article{Wu2024,
  author = {Wu, Yiqing and Tu, Mixue and Liu, Yifeng and Zhang, Dan},
  title = {GnRH agonist pretreatment for frozen embryo transfer among women with polycystic ovary syndrome: a narrow systematic review and meta-analysis of randomized controlled trials},
  journal = {Reproductive Biology and Endocrinology},
  year = {2024},
  doi = {10.1186/s12958-024-01293-9}
}
Kostenlos starten →